cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Stock Information for EV Biologics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About EV Biologics Inc

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion
Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets
cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval
cbdMD Generates $5.1 Million in Revenue, Positive Earnings
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.